Navigation Links
MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
Date:6/17/2008

because patients who are prescribed ondansetron often have difficulty swallowing due to extreme nausea caused by chemotherapy and radiation treatments. Following approval, ondansetron would be one of the first prescription drugs to come to market utilizing thin film drug delivery technology."

John A. MacPhee, president of Strativa, said, "We are delighted to collaborate with MonoSol Rx and expand our pipeline of supportive care products. With two unique, yet complementary delivery systems of ondansetron in our portfolio, Zensana(TM) oral spray and the oral thin film, we are able to offer patients a better opportunity to find a product that meets their individual needs."

Keith J. Kendall, executive vice president and CFO of MonoSol Rx, stated, "The financial components of this relationship demonstrate the value of MonoSol Rx's intellectual property, expertise in thin film development and manufacturing as well as our ability to partner for the commercialization of innovative thin film products."

About MonoSol Rx

MonoSol Rx is a drug delivery company specializing in proprietary, dissolving thin film pharmaceutical products. The Company's thin film technology, which is similar in size, shape and thickness to a postage stamp, dissolves rapidly and utilizes a novel process and proprietary encapsulation compositions to mask the taste of the drug contained within the film. The Company's thin film formulations offer significant patient benefits, including convenience, taste, and potentially greater efficacy. MonoSol Rx's strategy is to develop and partner innovative thin film strip products in the prescription, generic and OTC pharmaceutical markets and to establish a leadership position in thin film drug delivery technology through continued development of its drug delivery technology and intellectual property portfolio. For additional information, please visit http://www.monosolrx.com.

'/>"/>
SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations
2. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
3. Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients
4. KineMed Licenses GeneGos MetaCore
5. Xceed Molecular Licenses Signature from Moffitt Cancer Center and Adds Moffitt to Strategic Collaborator Program
6. Nuvo licenses topical pain product from Paladin
7. ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
8. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
9. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
10. Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo
11. RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Glidewell Laboratories, ... the launch of its CloudPoint™ family ... digital production of monolithic zirconia crowns & bridges, ... of providing the CAD/CAM-produced restorations that doctors demand. ... through which cases can be scanned, managed and ...
(Date:2/27/2015)... February 27, 2015 Healthpointe is ... suffered from injuries or diseases affecting the ... physicians are located throughout Southern California, and are ... to treat conditions related to the upper extremities. ... M. Ashley are board-certified and fully trained in ...
(Date:2/27/2015)... 2015 Insight Accelerator Labs has ... the development of an in-line urine flow meter ... being developed in direct response to current high ... and error margins with potentially grave consequences. The ... and provide trending data analysis to signal ICU ...
(Date:2/27/2015)... Chadds Ford, Pennsylvania (PRWEB) February 27, 2015 ... announces the Spring Breast Augmentation Special at his Chadds ... April 13 through May 1, 2015, and will be ... addition to the latest silicone implants, it will include ... reduced price and $250 worth of free Dysport. , ...
(Date:2/27/2015)... Miami Beach, Florida (PRWEB) February 27, 2015 ... largest non-profit organization devoted exclusively to funding innovative lymphoma ... series of education programs, outreach initiatives and patient services ... the South Florida community, returning to the greater Miami ... the La Gorce Country Club in Miami Beach on ...
Breaking Medicine News(10 mins):Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2
... to protect women against cervical cancer is available in ... 26, health officials said Friday. ,The Health Sciences ... Merck, Sharp and Dohme. A similar vaccine, Cervarix, from ... ,The vaccine represents a major health breakthrough, said Tay ...
... China's growing strengths in medical research, British Prime Minister ... medical excellence cluster' comprising universities and drugs companies. ... England to protect Britain's science base and boost its ... of measures initiated by government functionaries while citing the ...
... more people in China than tuberculosis or AIDS in each ... Ministry has prompted a// crackdown in the capital and other ... and poor quality rabies vaccines are to be blamed, the ... report findings on fake vaccines to the central government by ...
... in Ohio has donated $30 million to University Hospitals ... Ahuja, who had turned his graduate thesis into a ... on behalf of himself, his wife Usha and their ... plan called Vision 2010. ,In recognition of ...
... Daily steroids form a major part of anti-rejection medications ... long-term steroid use has significant side// effects. ... and slow growth rate in pediatric patients. Therefore, much ... avoiding the use of steroids in clinical organ transplantation. ...
... sudden unexplained deaths in England, reveals a nationwide study published ... figure is around eight times higher than previously thought, the ... cause of death judgments relating to sudden unexplained deaths in ... October 1997 and May 1999. ,The judgments were ...
Cached Medicine News:Health News:Britain Plans Medical Hub To Meet India, China Challenge 2Health News:Indian American Donates $30 Mn to Healthcare System 2Health News:Over 500 Sudden Unexplained Deaths Every Year, Mostly in Young Men 2
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... of studies in its neuroscience and oncology development ... 67 th American Academy of Neurology annual ... from April 18-25. The accepted abstracts feature results ... addition to investigational treatments in AbbVie,s pipeline. Presentations ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... its fourth quarter and full year 2014 financial results after ... In conjunction with the release, the Company will host a ... Eastern Time on Thursday, March 5, 2015 ... developments. Interested parties may access the live conference ...
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... Reportlinker.com announces that a new market research report is ... 10 CMOs in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html ... drivers, resistors and future outlook of CMO industry in ... analysis of the top 10 CMOs. Other leading players ...
... YORK, Jan. 25, 2011 Reportlinker.com announces that ... its catalogue: Emerging Regional Markets ... The overall emerging markets ... These regions include Latin America, China, Eastern Europe, ...
Cached Medicine Technology:Reportlinker Adds The Top 10 CMOs in China 2Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 2Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 3Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 4Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs 5
... is the soluble, extra-cellular domain of the Growth ... of the growth hormone-insulin-like growth factor (IGF) axis. ... a cleavage product of the GH receptor or ... Growth Hormone receptor cleavage /GHBP shedding is ...
... the most potent glucocorticoid produced by ... most cortisol is bound with high ... the remainder loosely bound to albumin. ... with effects in numerous physiologic systems, ...
... I (IGF-I or somatomedin C) is a 7.6 ... acts as a potent mitogen of cellular proliferation, ... receptors. In the circulation, IGF-I is bound to ... actions of IGF-I by modulating the interaction of ...
Inquire...
Medicine Products: